SAN
100.72
+1.15%↑
EI
250.8
-5.75%↓
SHL.DE
48.09
-2.89%↓
ARGX
545.4
+3.57%↑
FRE
39.69
+2.21%↑
SAN
100.72
+1.15%↑
EI
250.8
-5.75%↓
SHL.DE
48.09
-2.89%↓
ARGX
545.4
+3.57%↑
FRE
39.69
+2.21%↑
SAN
100.72
+1.15%↑
EI
250.8
-5.75%↓
SHL.DE
48.09
-2.89%↓
ARGX
545.4
+3.57%↑
FRE
39.69
+2.21%↑
SAN
100.72
+1.15%↑
EI
250.8
-5.75%↓
SHL.DE
48.09
-2.89%↓
ARGX
545.4
+3.57%↑
FRE
39.69
+2.21%↑
SAN
100.72
+1.15%↑
EI
250.8
-5.75%↓
SHL.DE
48.09
-2.89%↓
ARGX
545.4
+3.57%↑
FRE
39.69
+2.21%↑
24h
Actual
Mínimo
122.65
Máximo
126.6
Ingresos | -142M 667M |
---|---|
Ventas | 152M 5.4B |
P/B Media del Sector | 26.27 63.778 |
BPA | 2.2 |
Rentabilidad por dividendo | 1.34 |
Margen de beneficio | 12.311 |
EBITDA | 85M 1.6B |
Recomendaciones | Compra Fuerte |
---|---|
Estimación a 12 meses | +38.91% upside |
Rentabilidad por dividendo Media del Sector | 1.34% 2.39% |
---|---|
Próximas Ganancias | 15 may 2025 |
Capitalización de Mercado | 33B 98B |
---|---|
Apertura anterior | 124.49 |
Cierre anterior | 125.7 |
By Trading Central
Confianza
Strong Bearish Evidence
126.35 / 130.5 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
6 mar 2025, 06:27 UTC
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
DJ
Leer
11 feb 2025, 07:03 UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Leer
10 feb 2025, 16:38 UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Leer
6 mar 2025, 11:18 UTC
Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk
DJ
Leer
6 mar 2025, 11:14 UTC
Merck KGaA's Outlook Signals Greater Transparency -- Market Talk
DJ
Leer
6 mar 2025, 08:20 UTC
Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 Adj EPS EUR8.63
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 EBIT EUR3.645B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 After-Tax Profit EUR2.79B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 EBITDA EUR5.78B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 Sales EUR21.16B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20
DJ
Leer
6 mar 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Sales at EUR21.14B
DJ
Leer
6 mar 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B
DJ
Leer
11 feb 2025, 16:45 UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Leer
11 feb 2025, 10:54 UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Leer
11 feb 2025, 10:52 UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Leer
6 ene 2025, 13:08 UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Leer
6 ene 2025, 13:07 UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Leer
6 ene 2025, 13:06 UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Leer
6 ene 2025, 13:04 UTC
Merck KaA Acquires HUB Organoids Holding B.V. to Expand Its Next-Generation Biology Portfolio
DJ
Leer
17 dic 2024, 13:05 UTC
Merck: Deal Expected to Close By End Dec. 2024
DJ
Leer
17 dic 2024, 13:04 UTC
Merck: Terms of Deal Undisclosed
DJ
Leer
17 dic 2024, 13:04 UTC
Merck Signs Pact to Buy HUB Organoids
DJ
Leer
17 dic 2024, 13:03 UTC
Merck: Acquisition Advances Next Gen Biology Portfolio
DJ
Leer
17 dic 2024, 13:03 UTC
Merck to Buy HUB Organoids Holding
DJ
Leer
14 nov 2024, 11:15 UTC
Merck KGaA's Sales Target Dragged by Muted China Outlook -- Market Talk
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 175.86 EUR 38.91%
Máximo 190 EUR
Mínimo 160 EUR
De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merck KGaA Dist en los últimos 3 meses.
By TipRanks
Compra Fuerte
9 ratings
7
Comprar
2
Mantener
0
Vender
De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Merck KGaA Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Strong Bearish Evidence
All events are bearish.
Medio plazo
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Largo Plazo
Strong Bearish Evidence
All events are bearish.
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$